Fasting insulin levels were higher in NAFLD (8.9 vs. 5.7, p=0.08), and impaired fasting glucose prevalence was non-significantly higher (10% vs. 2%, p=0.204). This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.